During recent decades, the emergence of pathogenic fungi has posed an increasing public
health threat, particularly given the limited number of antifungal drugs available to treat …

The incidence of invasive fungal diseases (IFDs) is on the rise globally, particularly among
immunocompromised patients, leading to significant morbidity and mortality. Current clinical …

Over the past few decades, there has been a considerable rise in the incidence and
prevalence of pulmonary fungal infections, creating a global health problem due to a lack of …

Aspergillus species encompass a variety of infections, ranging from invasive aspergillosis to
allergic conditions, contingent upon the immune status of the host. In this spectrum …

Infections due to the Aspergillus species constitute an important challenge for human health.
Invasive aspergillosis represents a life-threatening disease, mostly in patients with immune …

Fungal rhinosinusitis (FRS) is a common problem worldwide, with an increasing burden in
arid climate regions. Aspergillus species are the most common causative agents involved. In …

Azole resistance in Aspergillus fumigatus poses a significant clinical challenge globally. Our
previous epidemiological analysis revealed a remarkably high frequency (~ 80%) of azole …

This study investigated whether sphingosine is effective as prophylaxis against Aspergillus
spp. and Candida spp. In vitro experiments showed that sphingosine is very efficacious …

Intraspecies variations that affect pathogenicity and antifungal resistance traits pose a
serious obstacle to efficient therapy of Candida auris infections. Recent reports indicate that …

Invasive infections caused by filamentous fungi have increased considerably due to the
alteration of the host's immune response. Aspergillus terreus is considered an emerging …